<DOC>
	<DOCNO>NCT00473057</DOCNO>
	<brief_summary>This open label study assess safety autologous bone marrow transplantation patient ischemic stroke middle cerebral artery territory within 90 day symptom onset .</brief_summary>
	<brief_title>Study Autologous Stem Cell Transplantation Patients With Ischemic Stroke</brief_title>
	<detailed_description>Objective : The purpose study evaluate safety feasibility intra-arterial intravenous injection autologous bone marrow mononuclear cell patient acute sub-acute phase ( &gt; 3 &lt; 90 day symptom onset ) ischemic cerebral infarct middle cerebral artery territory . Methods : 15 patient cerebral infarct within middle cerebral artery territory enrol prospective , nonrandomized , open-labeled study . Up 10 patient receive 500x 10 6 autologous bone marrow cell inject intra-arterially middle cerebral artery percutaneous approach . The procedure monitor Transcranial Doppler ( TCD ) electroencephalogram ( EEG ) . Other 5 patient receive 500x 10 6 autologous bone marrow cell inject intravenously . Changes neurological deficit improvement function evaluate baseline regular interval follow-up ( 4 month ) . EEG neuroimaging exam perform baseline regular interval follow-up period .</detailed_description>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Infarction , Middle Cerebral Artery</mesh_term>
	<criteria>clinical diagnosis ischemic stroke last 3 hour less 90 day symptom onset neuroimages exams show ischemic cerebral infarct middle cerebral artery territory age 18 75 year old NIHSS 4 20 spontaneous recanalization middle cerebral artery document TCD MRI sign informed consent difficult obtain vascular access percutaneous procedure vascular impossibility reach middle cerebral artery percutaneous approach severe carotid stenosis ( &gt; 70 % , Doppler ) relate severe stroke neurological worsening ( &gt; 4 point NIHSS ) due edema intracerebral hemorrhage primary hematological disease neurodegenerative disorder previous stroke mRS &gt; 2 intracardiac thrombosis autoimune disorder osteopathy could increase risk bone marrow harvest procedure thrombophilias liver failure chronic renal failure ( creatinine &gt; 2mg/ml ) life support dependence lacunar stroke pregnancy history neoplasia comorbidity could impact patient 's shortterm survival condition judgment investigator would place patient undue risk</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>May 2011</verification_date>
	<keyword>acute stroke</keyword>
	<keyword>middle cerebral artery</keyword>
	<keyword>autologous transplantation</keyword>
	<keyword>bone marrow cell</keyword>
	<keyword>stem cell</keyword>
	<keyword>cell therapy</keyword>
</DOC>